Extracorporeal membrane oxygenation depends on one foundational step before any blood ever reaches the circuit: getting reliable vascular access. ECMO cannulation is the process of placing large-bore cannulae into the vasculature so blood can be withdrawn, oxygenated externally, and returned to the patient, and the strategy chosen at this stage shapes nearly everything that follows in the patient's course on support. Because the cannulae must tolerate high flow rates for days to weeks at a time, their design and placement are approached with considerable care by the cannulation team.
What Determines VA vs VV Configuration Choice?
The first branch point in any ECMO plan is whether the patient needs venoarterial (VA) or venovenous (VV) support, and the decision generally comes down to whether the heart itself needs assistance. VA ECMO withdraws venous blood, oxygenates it, and returns it to the arterial system, effectively bypassing both the heart and lungs and providing hemodynamic support in addition to gas exchange. VV ECMO, by contrast, withdraws and returns blood entirely within the venous system, supporting gas exchange while leaving the patient's own cardiac output to circulate blood throughout the body. Clinicians commonly reserve VA ECMO for cases involving cardiogenic shock or combined cardiopulmonary failure, while VV ECMO is more typically associated with isolated respiratory failure where cardiac function remains adequate. The distinction matters directly for cannulation strategy, since VA configurations require both venous and arterial access sites while VV configurations may be achieved through venous access alone, sometimes via a single dual-lumen cannula.
How Does Percutaneous Cannulation Differ From Surgical Cutdown?
Percutaneous cannulation uses a needle-guidewire-dilator sequence, often under ultrasound guidance, to advance cannulae through the skin and into the target vessel without an open surgical incision. This approach is widely used for femoral and internal jugular access because it can be performed quickly at the bedside, which matters in urgent or emergent initiation scenarios. Surgical cutdown, by comparison, involves directly exposing the vessel through an incision before cannula insertion, which can offer more controlled visualization of vessel caliber and any anatomical variation, and may be favored in patients with difficult peripheral anatomy or when central cannulation is planned. Many programs use a hybrid approach, starting percutaneously and converting to a cutdown if access proves difficult. The choice between these techniques is generally made by the cannulating physician based on patient anatomy, urgency, and available resources rather than a fixed protocol.
Why Does Cannula Design Affect Flow and Complication Risk?
Cannula geometry is not incidental to ECMO performance. Drainage (venous) cannulae are typically designed with multiple side holes along their distal segment to maximize surface area for blood withdrawal and reduce the risk of the cannula tip occluding against a vessel wall, since inadequate drainage can limit achievable circuit flow regardless of pump capability. Return cannulae, which deliver oxygenated blood back to the patient, are generally shorter and prioritize a smooth internal lumen to minimize turbulence and shear stress on blood components. Wall thickness and outer diameter are balanced against the need for a large internal lumen, since a cannula with a narrow bore relative to its length increases resistance and can limit flow, while an oversized cannula relative to the vessel can compromise distal limb perfusion, particularly in femoral arterial access. Reinforced or wire-braided cannula walls are commonly used to resist kinking during patient positioning or transport, since kinking can abruptly interrupt flow. Distal limb perfusion catheters are frequently added alongside femoral arterial cannulae specifically to address the risk of limb ischemia distal to the cannulation site.
What Complications Are Associated With ECMO Access Sites?
Vascular access complications remain among the most frequently reported issues associated with ECMO support. Bleeding at the cannulation site is common given the combination of large-bore access and the systemic anticoagulation typically required to prevent circuit thrombosis. Limb ischemia distal to a femoral arterial cannula is a recognized risk, which is why perfusion of the distal limb is generally monitored closely throughout the support period. Vessel injury, including dissection during insertion, and cannula-associated infection over prolonged support durations are also documented concerns. Because these risks are inherent to the technique rather than tied to a specific device, care teams generally weigh cannulation site selection, cannula sizing, and monitoring protocols together rather than relying on any single safeguard.
INVAMED's broader cardiac surgery instruments portfolio, which includes venous and arterial cannulae designed for cardiopulmonary bypass and ECMO applications, can be reviewed on the Cardiac Surgery Instruments category page.
Is VA ECMO the same as cardiopulmonary bypass?
No. Cardiopulmonary bypass is a short-duration, closed-circuit technique used during open-heart surgery, typically for hours. VA ECMO is intended for longer-duration support, ranging from days to weeks, and is used to manage cardiogenic shock or respiratory failure outside the operating room, though the underlying principle of extracorporeal circulation is related.
Can ECMO cannulation be reversed or converted after initiation?
Yes, in many cases. Patients can be transitioned between VA and VV configurations, or from peripheral to central cannulation, if their clinical status changes. These decisions are made by the treating care team based on ongoing hemodynamic and respiratory assessment.
Does cannula size affect how much blood flow ECMO can provide?
Yes, cannula internal diameter and length are major determinants of achievable flow, alongside pump function and patient vascular anatomy. Clinicians typically select cannula size based on patient body size, target flow requirements, and vessel caliber measured before insertion.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
